Jing Jin

2.5k total citations · 1 hit paper
79 papers, 1.8k citations indexed

About

Jing Jin is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Jing Jin has authored 79 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 20 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Jing Jin's work include Colorectal and Anal Carcinomas (10 papers), Colorectal Cancer Surgical Treatments (9 papers) and Inflammatory Biomarkers in Disease Prognosis (9 papers). Jing Jin is often cited by papers focused on Colorectal and Anal Carcinomas (10 papers), Colorectal Cancer Surgical Treatments (9 papers) and Inflammatory Biomarkers in Disease Prognosis (9 papers). Jing Jin collaborates with scholars based in China, United States and United Kingdom. Jing Jin's co-authors include Xuetao Cao, Chaofeng Han, Nan Li, Haibo Liu, Sheng Xu, Dan Liu, Hua Sun, Geng-Tao Liu, Weimin Li and Lan Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jing Jin

76 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rare-Earth-Modified NiS₂ Improves OH Coverage for an Industrial Alkaline Water Electrolyzer

2024 91 citations Jing Jin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jing Jin China	24	675	555	500	238	210	79	1.8k
Qi Xie China	22	403 0.6×	519 0.9×	436 0.9×	278 1.2×	150 0.7×	87	1.6k
Quintin Pan United States	20	739 1.1×	756 1.4×	189 0.4×	370 1.6×	261 1.2×	40	1.8k
Zhihai Peng China	27	425 0.6×	764 1.4×	115 0.2×	280 1.2×	158 0.8×	79	1.7k
Tingting Zeng China	27	486 0.7×	1.2k 2.2×	254 0.5×	716 3.0×	226 1.1×	96	2.0k
Hongbo Wang China	22	301 0.4×	765 1.4×	197 0.4×	446 1.9×	210 1.0×	99	1.8k
Run Lin China	19	390 0.6×	383 0.7×	360 0.7×	180 0.8×	175 0.8×	46	1.5k
Jiaqi Wu China	21	422 0.6×	675 1.2×	279 0.6×	354 1.5×	279 1.3×	120	1.7k
Yi‐Ting Chen Taiwan	19	311 0.5×	380 0.7×	184 0.4×	143 0.6×	167 0.8×	103	1.2k
Meng Xia China	26	397 0.6×	1.3k 2.3×	314 0.6×	507 2.1×	172 0.8×	93	2.3k

Countries citing papers authored by Jing Jin

Since Specialization

Citations

This map shows the geographic impact of Jing Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Jin more than expected).

Fields of papers citing papers by Jing Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Jin. The network helps show where Jing Jin may publish in the future.

Co-authorship network of co-authors of Jing Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Jin. A scholar is included among the top collaborators of Jing Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Jin. Jing Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Jinming, et al.. (2025). CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer. Cell Death and Disease. 16(1). 641–641. 1 indexed citations

Gao, Xinming, et al.. (2024). Functional insights of digestion, absorption, and immunity in different segments of the intestine in Hemibarbus labeo from transcriptomic analysis. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 52. 101278–101278. 2 indexed citations

Zeng, Qiang, Yuexin Yang, Yuan Tang, et al.. (2024). Prognostic and Predictive Value of a Modified Diagnostic Biopsy-Adapted Immunoscore in Patients with Rectal Cancer After Neoadjuvant Treatment: A Translational Study From the STELLAR Trial. International Journal of Radiation Oncology*Biology*Physics. 121(3). 640–650.

Xu, Xinyuan, Qian Zhang, Xufeng Wang, et al.. (2023). Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo. Acta Pharmaceutica Sinica B. 14(3). 1302–1316. 9 indexed citations

Jin, Jing, Chengdi Wang, Pengwei Ren, et al.. (2023). Common nutritional/inflammatory indicators are not effective tools in predicting the overall survival of patients with small cell lung cancer undergoing first-line chemotherapy. Frontiers in Oncology. 13. 1211752–1211752. 3 indexed citations

Liu, Xue, Mingjin Wang, Baolian Wang, et al.. (2022). Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists. European Journal of Medicinal Chemistry. 246. 114943–114943. 5 indexed citations

Jin, Jing, et al.. (2021). Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review). International Journal of Oncology. 59(1). 9 indexed citations

Yu, Xiaoting, Lili Sun, Yanwen Zheng, et al.. (2020). GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway. Oncogene. 39(27). 5042–5055. 63 indexed citations

Chang, Fung-Wei, Hueng‐Chuen Fan, Jui‐Ming Liu, et al.. (2017). Estrogen Enhances the Expression of the Multidrug Transporter Gene ABCG2—Increasing Drug Resistance of Breast Cancer Cells through Estrogen Receptors. International Journal of Molecular Sciences. 18(1). 163–163. 40 indexed citations

10.

Li, Ning, Jing Jin, Shuai Li, et al.. (2017). Prognostic factors in patients with stage yp0-I rectal cancer after preoperative concurrent chemoradiotherapy. Zhonghua fangshe zhongliuxue zazhi. 26(3). 296–301. 2 indexed citations

11.

Jin, Jing, Kejia Hu, Yongzhao Zhou, & Weimin Li. (2017). Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis. PLoS ONE. 12(9). e0184412–e0184412. 53 indexed citations

12.

Zhao, Zhenhua, Lumei Wang, Muyun Liu, et al.. (2016). Modified tissue culture for C57BL/6 mouse pancreatic stellate cells. 16(1). 34–37. 1 indexed citations

13.

Wang, Lan, Jie Yin, Xuefei Wang, et al.. (2016). C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Gastroenterology. 150(5). 1183–1195.e16. 49 indexed citations

14.

Hu, Xiang, Chaofeng Han, Jing Jin, et al.. (2016). Integrin CD11b attenuates colitis by strengthening Src-Akt pathway to polarize anti-inflammatory IL-10 expression. Scientific Reports. 6(1). 26252–26252. 28 indexed citations

15.

He, Yutong, Daojuan Li, Guohui Song, et al.. (2016). Lung cancer burden has increased during the last 40 years in Hebei Province, China. Thoracic Cancer. 7(3). 323–332. 16 indexed citations

16.

Jin, Jing, Ying Ding, Yen Lin Chee, et al.. (2013). Direct costs associated with febrile neutropenia in inpatients with hematological diseases in Singapore. Supportive Care in Cancer. 22(6). 1447–1451. 7 indexed citations

17.

Ryu, Han Suk, Jin-Haeng Chung, Kyoung Bun Lee, et al.. (2012). Overexpression of epithelial-mesenchymal transition–related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma. Human Pathology. 43(12). 2360–2370. 24 indexed citations

18.

Jin, Jing, Yu-Xiang Zheng, William E. Boeglin, & Alan Brash. (2012). Biosynthesis, isolation, and NMR analysis of leukotriene A epoxides: substrate chirality as a determinant of the cis or trans epoxide configuration. Journal of Lipid Research. 54(3). 754–761. 9 indexed citations

19.

Jin, Jing, Ye‐Xiong Li, Yueping Liu, et al.. (2005). A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 64(3). 725–729. 15 indexed citations

20.

Jin, Jing, et al.. (2004). Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Cancer Chemotherapy and Pharmacology. 55(2). 179–188. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact